Global Neurological Biomarkers Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
153
Industry
Automotive Parts
Regions
Global
Updated
February 2026

Report Overview


Report Overview
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent. In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.

The global Neurological Biomarkers market size was estimated at USD 8687.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Neurological Biomarkers market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Neurological Biomarkers market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurological Biomarkers market.
Global Neurological Biomarkers Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz

Market Segmentation (by Type)
Proteomics
Genomics
Imaging
Bioinformatics
Others

Market Segmentation (by Application)
Diagnostics
Drug Discovery
Personalized Medicine
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurological Biomarkers Market
Overview of the regional outlook of the Neurological Biomarkers Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Biomarkers Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Neurological Biomarkers, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Neurological Biomarkers
    • 1.2 Key Market Segments
      • 1.2.1 Neurological Biomarkers Segment by Type
      • 1.2.2 Neurological Biomarkers Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Neurological Biomarkers Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Neurological Biomarkers Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Neurological Biomarkers Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Neurological Biomarkers Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Neurological Biomarkers Product Life Cycle
    • 3.3 Global Neurological Biomarkers Sales by Manufacturers (2020-2025)
    • 3.4 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Neurological Biomarkers Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Neurological Biomarkers Market Competitive Situation and Trends
      • 3.8.1 Neurological Biomarkers Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Neurological Biomarkers Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Neurological Biomarkers Industry Chain Analysis
    • 4.1 Neurological Biomarkers Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Neurological Biomarkers Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Neurological Biomarkers Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Neurological Biomarkers Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Neurological Biomarkers Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Neurological Biomarkers Sales Market Share by Type (2020-2025)
    • 6.3 Global Neurological Biomarkers Market Size by Type (2020-2025)
    • 6.4 Global Neurological Biomarkers Price by Type (2020-2025)
  • 7 Neurological Biomarkers Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Neurological Biomarkers Market Sales by Application (2020-2025)
    • 7.3 Global Neurological Biomarkers Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Neurological Biomarkers Sales Growth Rate by Application (2020-2025)
  • 8 Neurological Biomarkers Market Sales by Region
    • 8.1 Global Neurological Biomarkers Sales by Region
      • 8.1.1 Global Neurological Biomarkers Sales by Region
      • 8.1.2 Global Neurological Biomarkers Sales Market Share by Region
    • 8.2 Global Neurological Biomarkers Market Size by Region
      • 8.2.1 Global Neurological Biomarkers Market Size by Region
      • 8.2.2 Global Neurological Biomarkers Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Neurological Biomarkers Sales by Country
      • 8.3.2 North America Neurological Biomarkers Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Neurological Biomarkers Sales by Country
      • 8.4.2 Europe Neurological Biomarkers Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Neurological Biomarkers Sales by Region
      • 8.5.2 Asia Pacific Neurological Biomarkers Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Neurological Biomarkers Sales by Country
      • 8.6.2 South America Neurological Biomarkers Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Neurological Biomarkers Sales by Region
      • 8.7.2 Middle East and Africa Neurological Biomarkers Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Neurological Biomarkers Market Production by Region
    • 9.1 Global Production of Neurological Biomarkers by Region(2020-2025)
    • 9.2 Global Neurological Biomarkers Revenue Market Share by Region (2020-2025)
    • 9.3 Global Neurological Biomarkers Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Neurological Biomarkers Production
      • 9.4.1 North America Neurological Biomarkers Production Growth Rate (2020-2025)
      • 9.4.2 North America Neurological Biomarkers Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Neurological Biomarkers Production
      • 9.5.1 Europe Neurological Biomarkers Production Growth Rate (2020-2025)
      • 9.5.2 Europe Neurological Biomarkers Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Neurological Biomarkers Production (2020-2025)
      • 9.6.1 Japan Neurological Biomarkers Production Growth Rate (2020-2025)
      • 9.6.2 Japan Neurological Biomarkers Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Neurological Biomarkers Production (2020-2025)
      • 9.7.1 China Neurological Biomarkers Production Growth Rate (2020-2025)
      • 9.7.2 China Neurological Biomarkers Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Thermo Fisher Scientific
      • 10.1.1 Thermo Fisher Scientific Basic Information
      • 10.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Overview
      • 10.1.3 Thermo Fisher Scientific Neurological Biomarkers Product Market Performance
      • 10.1.4 Thermo Fisher Scientific Business Overview
      • 10.1.5 Thermo Fisher Scientific SWOT Analysis
      • 10.1.6 Thermo Fisher Scientific Recent Developments
    • 10.2 Merck
      • 10.2.1 Merck Basic Information
      • 10.2.2 Merck Neurological Biomarkers Product Overview
      • 10.2.3 Merck Neurological Biomarkers Product Market Performance
      • 10.2.4 Merck Business Overview
      • 10.2.5 Merck SWOT Analysis
      • 10.2.6 Merck Recent Developments
    • 10.3 Quest Diagnostics
      • 10.3.1 Quest Diagnostics Basic Information
      • 10.3.2 Quest Diagnostics Neurological Biomarkers Product Overview
      • 10.3.3 Quest Diagnostics Neurological Biomarkers Product Market Performance
      • 10.3.4 Quest Diagnostics Business Overview
      • 10.3.5 Quest Diagnostics SWOT Analysis
      • 10.3.6 Quest Diagnostics Recent Developments
    • 10.4 Abbott
      • 10.4.1 Abbott Basic Information
      • 10.4.2 Abbott Neurological Biomarkers Product Overview
      • 10.4.3 Abbott Neurological Biomarkers Product Market Performance
      • 10.4.4 Abbott Business Overview
      • 10.4.5 Abbott Recent Developments
    • 10.5 Roche
      • 10.5.1 Roche Basic Information
      • 10.5.2 Roche Neurological Biomarkers Product Overview
      • 10.5.3 Roche Neurological Biomarkers Product Market Performance
      • 10.5.4 Roche Business Overview
      • 10.5.5 Roche Recent Developments
    • 10.6 Illumina
      • 10.6.1 Illumina Basic Information
      • 10.6.2 Illumina Neurological Biomarkers Product Overview
      • 10.6.3 Illumina Neurological Biomarkers Product Market Performance
      • 10.6.4 Illumina Business Overview
      • 10.6.5 Illumina Recent Developments
    • 10.7 Bio-Rad Laboratories
      • 10.7.1 Bio-Rad Laboratories Basic Information
      • 10.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Overview
      • 10.7.3 Bio-Rad Laboratories Neurological Biomarkers Product Market Performance
      • 10.7.4 Bio-Rad Laboratories Business Overview
      • 10.7.5 Bio-Rad Laboratories Recent Developments
    • 10.8 QIAGEN
      • 10.8.1 QIAGEN Basic Information
      • 10.8.2 QIAGEN Neurological Biomarkers Product Overview
      • 10.8.3 QIAGEN Neurological Biomarkers Product Market Performance
      • 10.8.4 QIAGEN Business Overview
      • 10.8.5 QIAGEN Recent Developments
    • 10.9 Myriad RBM
      • 10.9.1 Myriad RBM Basic Information
      • 10.9.2 Myriad RBM Neurological Biomarkers Product Overview
      • 10.9.3 Myriad RBM Neurological Biomarkers Product Market Performance
      • 10.9.4 Myriad RBM Business Overview
      • 10.9.5 Myriad RBM Recent Developments
    • 10.10 Cisbio Bioassays
      • 10.10.1 Cisbio Bioassays Basic Information
      • 10.10.2 Cisbio Bioassays Neurological Biomarkers Product Overview
      • 10.10.3 Cisbio Bioassays Neurological Biomarkers Product Market Performance
      • 10.10.4 Cisbio Bioassays Business Overview
      • 10.10.5 Cisbio Bioassays Recent Developments
    • 10.11 Athena Diagnostics
      • 10.11.1 Athena Diagnostics Basic Information
      • 10.11.2 Athena Diagnostics Neurological Biomarkers Product Overview
      • 10.11.3 Athena Diagnostics Neurological Biomarkers Product Market Performance
      • 10.11.4 Athena Diagnostics Business Overview
      • 10.11.5 Athena Diagnostics Recent Developments
    • 10.12 BGI
      • 10.12.1 BGI Basic Information
      • 10.12.2 BGI Neurological Biomarkers Product Overview
      • 10.12.3 BGI Neurological Biomarkers Product Market Performance
      • 10.12.4 BGI Business Overview
      • 10.12.5 BGI Recent Developments
    • 10.13 Wuxi APP
      • 10.13.1 Wuxi APP Basic Information
      • 10.13.2 Wuxi APP Neurological Biomarkers Product Overview
      • 10.13.3 Wuxi APP Neurological Biomarkers Product Market Performance
      • 10.13.4 Wuxi APP Business Overview
      • 10.13.5 Wuxi APP Recent Developments
    • 10.14 Aepodia
      • 10.14.1 Aepodia Basic Information
      • 10.14.2 Aepodia Neurological Biomarkers Product Overview
      • 10.14.3 Aepodia Neurological Biomarkers Product Market Performance
      • 10.14.4 Aepodia Business Overview
      • 10.14.5 Aepodia Recent Developments
    • 10.15 Proteome Sciences
      • 10.15.1 Proteome Sciences Basic Information
      • 10.15.2 Proteome Sciences Neurological Biomarkers Product Overview
      • 10.15.3 Proteome Sciences Neurological Biomarkers Product Market Performance
      • 10.15.4 Proteome Sciences Business Overview
      • 10.15.5 Proteome Sciences Recent Developments
    • 10.16 Genewiz
      • 10.16.1 Genewiz Basic Information
      • 10.16.2 Genewiz Neurological Biomarkers Product Overview
      • 10.16.3 Genewiz Neurological Biomarkers Product Market Performance
      • 10.16.4 Genewiz Business Overview
      • 10.16.5 Genewiz Recent Developments
  • 11 Neurological Biomarkers Market Forecast by Region
    • 11.1 Global Neurological Biomarkers Market Size Forecast
    • 11.2 Global Neurological Biomarkers Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Neurological Biomarkers Market Size Forecast by Country
      • 11.2.3 Asia Pacific Neurological Biomarkers Market Size Forecast by Region
      • 11.2.4 South America Neurological Biomarkers Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Neurological Biomarkers by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Neurological Biomarkers Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Neurological Biomarkers by Type (2026-2035)
      • 12.1.2 Global Neurological Biomarkers Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Neurological Biomarkers by Type (2026-2035)
    • 12.2 Global Neurological Biomarkers Market Forecast by Application (2026-2035)
      • 12.2.1 Global Neurological Biomarkers Sales (K MT) Forecast by Application
      • 12.2.2 Global Neurological Biomarkers Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.